Document:

EX-10.30

 Exhibit 10.30 

WAIVER AND AMENDMENT TO 

STOCKHOLDERS AGREEMENT, LIMITED LIABILITY COMPANY AGREEMENT AND OPTION TO PURCHASE 

This Waiver and Amendment (this “Waiver and Amendment”) to (i) that certain Stockholders Agreement by and among Change
Healthcare Inc. (f/k/a HCIT Holdings, Inc.) (“Change Healthcare Inc.”), Change Healthcare LLC, McKesson Corporation (“McK”) and the Sponsors, Other Investors and Managers named therein, dated as of March 1,
2017 (the “Stockholders Agreement”), (ii) that certain Third Amended and Restated Limited Liability Company Agreement of Change Healthcare LLC, dated as of March 1, 2017 (the “LLCA”) and (iii) that certain
Option to Enter into a Purchase Agreement by and among the Connect Parties named therein, the Company Parties named therein, the Sponsors named therein and the Echo Shareholders named therein, dated as of February 28, 2017 (the “Option
to Purchase”), is entered into as of May 30, 2019 by and among Change Healthcare Inc., Change Healthcare LLC, McK, Change Healthcare Solutions, LLC and the requisite holders of Echo Shares (as defined in the Stockholders Agreement) as
provided in Section 7.7(b) of the Stockholders Agreement (each a “Party” and collectively the “Parties”). 

WHEREAS, each of the Parties desires to waive or amend the provisions of the Stockholders Agreement, LLCA and Option to Purchase as set forth
herein. 
 WAIVER AND AMENDMENT 

NOW THEREFORE, in consideration of the mutual agreements and covenants set forth below, the parties hereto agree as follows: 

A.    Amendment of the Stockholders Agreement. The Stockholders Agreement is hereby amended as follows: 

(1)    Section 2.4(b) of the Stockholders Agreement is hereby amended and restated in its entirety as follows: 

Class X Stock. Following a Qualified IPO, and prior to the MCK Trigger Date, in the event Echo breaches the terms
of, or otherwise fails to take any action then required to be taken pursuant to the terms of, the Agreement and Plan of Merger, between Echo and MCK dated December 20, 2016, as amended, replaced or supplemented from time to time (the
“Merger Agreement,” and/or the merger contemplated by the Merger Agreement and/or the LLC Agreement, the “Merger”), including for the avoidance of doubt, the failure to obtain any necessary approval of the Board of
Directors or Stockholders of Echo required in connection with the Merger, then following the delivery to Echo by MCK of a written notice of such breach or failure, Echo, the Sponsors and the Stockholders shall take all Necessary Action to promptly
issue to MCK (or one of its designated Affiliates) one (1) share of Class X Stock for the legal minimum consideration for such share which, when issued in accordance with the terms hereof, shall be duly authorized and validly issued, fully
paid and non-assessable, and have the rights set forth in the Articles. 

 (2)    Section 3.1(b) of the Stockholders Agreement is hereby amended
and restated in its entirety as follows: 
 (b)    Post-IPO Board of
Directors. Effective immediately prior to a Qualified IPO and in connection with the consummation of a Qualified IPO, the Stockholders and Echo shall take all Necessary Action to cause the Board of Directors to be comprised of such directors as
Majority Blackstone Investors shall designate; provided, that (i) such Board of Directors shall meet any and all applicable Independence Requirements and the other rules and regulations of the SEC and any applicable stock exchange and
(ii) such designees shall only be appointed to the Board of Directors to serve for terms of no more than one (1) year. Following such Qualified IPO and prior to consummation of a Qualified MCK Exit, for so long as Stockholders (together
with their Permitted Transferees and Affiliates) collectively continue to hold forty percent (40%) or more of the aggregate number of shares of Common Stock entitled to vote generally in the election of directors as of the record date for such
meeting, the Majority Blackstone Investors shall be entitled to nominate to the Board of Directors a number of directors equal to a majority of the total members of the Board of Directors. Following a Qualified MCK Exit, for so long as Blackstone
(together with its Permitted Transferees and Affiliates) continues to hold fifty percent (50%) or more of the aggregate number of shares of Common Stock issued to Blackstone on the date hereof (as appropriately adjusted for any stock split, stock
dividend, combination, recapitalization or the like), the Majority Blackstone Investors shall be entitled to nominate to the Board of Directors a number of directors equal to a majority of the total members of the Board of Directors minus one
director (the “Post-MCK Exit Level”). Notwithstanding anything otherwise to the contrary herein, at all times following a Qualified IPO, for so long as Blackstone (together with its Permitted
Transferees and Affiliates) continues to hold five percent (5%) or more of the aggregate number of shares of Common Stock entitled to vote generally in the election of directors as of the record date for such meeting, the Majority Blackstone
Investors shall be entitled to nominate not fewer than two directors to the Board of Directors; provided, that following a Qualified MCK Exit, the Majority Blackstone Investors shall in no event be entitled to nominate a number of directors
that would result in a number of nominees in excess of the Post-MCK Exit Level. 

(3)    Section 7.9(ii) of the Stockholders Agreement is hereby amended and restated in its entirety as follows: 

(ii)    if to H&F, to: 

c/o Hellman & Friedman LLC 

415 Mission Street 
 Suite 5700

 San Francisco, California 94105 

Attention:     Allen R. Thorpe 

                     Arrie R. Park

 Facsimile:    [fax number] 

 with a copy (which shall not constitute notice) to: 

Simpson Thacher & Bartlett LLP 

2475 Hanover Street 
 Palo Alto,
California 94304 
 Attention:     Atif Azher 

Facsimile:    [fax number] 

(4)    The Stockholders Agreement is hereby amended by inserting a new Section 7.17 as follows: 

Section 7.17 Certain Recipients of Awards. For the avoidance of doubt, and notwithstanding anything to the contrary in this Agreement
or otherwise, the Stockholders hereby agree that (i) each Person who first receives an Award (as defined in the HCIT Holdings, Inc. Amended and Restated 2009 Equity Incentive Plan) after March 1, 2017 (a “Post-Closing
Awardee”) (x) is not, and shall at no time be, a Stockholder under this Agreement and (y) has, and shall have, no rights or obligations of any kind whatsoever under or with respect to this Agreement, and (ii) this
Section 7.17 shall have no effect on the status under this Agreement of any Person who held Echo Shares as of March 1, 2017 or who received an Award (including, but not limited to, Awards comprising unvested restricted shares of Common
Stock) in connection with the closing of the transactions contemplated by the Contribution Agreement. Notwithstanding the foregoing clause (i), a Post-Closing Awardee may be joined to this Agreement pursuant to an agreement that (A) expressly
refers to this Section 7.17, (B) states that the Post-Closing Awardee is being joined to this Agreement notwithstanding Section 7.17 and (C) is signed by all the parties hereto that would be
required to amend this Section 7.17. 
 B.    Amendment of the LLCA. The LLCA is hereby
amended as follows: 
 (1)    The following definitions in the LLCA are hereby amended and restated in their entirety as
follows: 
 “Adjustment Event” means, without duplication, (i) the filing by the Company of any amended U.S.
federal income tax return, (ii) a “determination” as defined in Code Section 1313(a) and (iii) any other event (including the execution of IRS Form 870-AD) that finally and
conclusively establishes the amount of any liability of any Member or former Member (or their respective current and former Affiliates) for U.S. federal income tax in respect of (x) any item of income, gain, loss or deduction of the Company
(each, a “Company Item”) for any taxable period, (y) any item of income, gain, loss or deduction of such Member attributable to the treatment as taxable of any issuance, repurchase, redemption or distribution by the Company to
Echo described in Section 3.03(c) in connection with any Approved Plan or a redemption or repurchase of Echo Shares pursuant to the terms of the Echo Shareholders Agreement (each, an “Echo Benefit Plan Item”), or (z) any
item of income, gain, loss or deduction of such Member attributable to the availability or unavailability of any interest deduction to such Member under Section 163(j)(4)(B) of the Code (a “Carryforward Interest Item”) excluding, for
the avoidance of doubt, any event establishing the liability of the Company for an “imputed underpayment” under Section 6225 of the Partnership Tax Audit Rules for which an election under Section 6226 of the Partnership Tax Audit
Rules is not made. 

 “Adjustment Tax Year Amount” means, for any Adjustment Event, any Member
and any Tax Year to which such Adjustment Event relates, an amount, which may be positive or negative, determined by multiplying (i) the Applicable Tax Rate (as determined for such Tax Year) by (ii) (A) the sum of (x) the net amount
of Company Items allocable to such Member (y) the net amount of Echo Benefit Plan Items recognized by such Member and (z) the net amount of any Carryforward Interest Items recognized by such Member, for such Tax Year after giving effect to
such Adjustment Event (including any correlative adjustments to Company Items), minus (B) the sum of (x) the net amount of Company Items allocable to such Member, (y) the net amount of Echo Benefit Plan Items recognized by such Member
and (z) the net amount of any Carryforward Interest Items, for such Tax Year before giving effect to such Adjustment Event (but, for the avoidance of doubt, after giving effect to any prior Adjustment Event). 

“Annual Tax Distribution Amount” means with respect to a Member for a Tax Year, an amount equal to the product of
(a) the excess of (x) the aggregate amount of net taxable income and gain allocated to such Member with respect to the Units pursuant to Section 8.01(c) for such Tax Year over (y) the amount of any deduction available to such
Member for such Tax Year as a result of the application of Section 163(j)(4)(B) to business interest incurred by the Company in a prior Tax Year and (b) the Applicable Tax Rate. 

“Estimated Tax Distribution Amount” means, with respect to a Member for each Estimated Tax Distribution Period of a Tax Year,
an amount equal to (a) the product of (i) the excess of (x) the estimated aggregate amount of taxable income and gain allocated to such Member with respect to such Member’s Units pursuant to Section 8.01(c) for such Tax Year
through the end of such Estimated Tax Distribution Period over (y) the estimated amount of any deduction available to such Member for such Tax Year through the end of such Estimated Tax Distribution Period as a result of the application of
Section 163(j)(4)(B) to business interest incurred by the Company in a prior Tax Year, in each case as determined by the Board prior to the date of distribution pursuant to Section 8.02(a)(i) with respect to such Estimated Tax Distribution
Period, and (ii) the Applicable Tax Rate less (b) the sum of the Estimated Tax Distribution Amount(s) previously calculated in respect of the previous Estimated Tax Distribution Period(s) with respect to such Tax Year. 

(2)    Section 8.01(b)(i) of the LLCA is hereby amended by adding the following parenthetical to the end of the proviso
thereof: “(it being understood for the avoidance of doubt that any allocation of Depreciation in respect of the MCK IPCo Owned Intellectual Property to Echo pursuant to this proviso shall be treated as having been made pursuant to paragraph
3(b) of that certain Amended and Restated Letter Agreement Relating to Agreement of Contribution and Sale dated as of September 28, 2018 by and among MCK, the MCK Members, Echo, the Company and Change Healthcare Holdings, LLC)”. 

 (3)    Section 11.04(d)(vi) of the LLCA is hereby amended and restated
in its entirety, with effect from and after the date hereof, as follows: 
 “(vi) (A) from May 30, 2019 (the
“Amendment Start Date”) until the date on which the MCK Exit Window terminates or expires, if any such date occurs prior to the date that the right of the MCK Members to approve Reserved Matters terminates pursuant to
Section 5.05(b) (such termination or expiration date, the “Amendment End Date”), and in each case (A) except as expressly contemplated in this Agreement (but including pursuant to an Approved Echo
Plan) or (B) except as expressly approved by the compensation committee of the Company or Echo, which such approval includes the approval of an employee or designee of the MCK Member or its Affiliates, as evidenced in the minutes of the
applicable meeting or in the unanimous written consent, (1) any modification, waiver, or amendment of the terms of any Echo Shares or other Equity Securities of Echo or its Subsidiaries that were outstanding as of the Amendment Start Date
(“Grandfathered Echo Securities”), or (2) other than pursuant to the terms of Grandfathered Echo Securities, any issuance, or authorization of issuance, grant or other award of any Echo Shares or other Equity Securities of Echo
or its Subsidiaries, or any amendment to, modification of, or waiver of the terms of any issuance, grant or other award of any Echo Shares or other Equity Securities of Echo or its Subsidiaries; or 

(B) prior to the Amendment Start Date and on or after the Amendment End Date, any issuance, or authorization of issuance, of any Echo Shares
or other Equity Securities of Echo or its Subsidiaries, except as expressly contemplated in this Agreement and excluding the issuance of any Equity Securities of Echo or its Subsidiaries pursuant to awards approved by the Board under any Approved
Echo Plan;” 
 C.    Waiver and Agreement in respect of the Option to Purchase. Each of McK, Change
Healthcare Inc., Change Healthcare LLC and Change Solutions hereby agrees and consents as required under the Stockholders Agreement and LLCA (including Section 5.05 thereof) as follows: 

(1)    For the purposes of this Waiver and Amendment, “eRx Cash” means cash and cash equivalents of eRx Network
Holdings, Inc, and its subsidiaries determined in accordance with generally accepted accounting principles, in effect from time to time, minus (i) deposits in transit, cash overdrafts, outstanding checks, and negative bank balances, minus
(ii) restricted cash. 
 (2)    That the Purchase Price under the Option to Purchase will be increased by an amount
equal to eRx Cash as of 12:01am (New York time) on the day of Closing (as defined in the Option to Purchase). 

(3)    That notwithstanding the restrictive covenants contained in Section 8(a) of the Option to Purchase or any
other agreements among the parties, the Connect Parties will be permitted, following the earlier of (i) the date of the Echo Option Trigger (as defined in the Option to Purchase) or (ii) the expiration or termination of the MCK Exit Window
(as defined in the LLCA), to distribute any eRx Cash from time to time prior to the Business Day prior to the Closing (as defined in the Option to Purchase) to the Echo Shareholders, so long as (A) such distribution is made pro rata among the
Echo Shareholders and (B) if such distribution is made following the expiration or termination of the MCK Exit Window but prior to the date of the Echo Option Trigger, any such eRx Cash distributed, in the determination of the board of
directors of eRx, is not otherwise reasonably necessary to operate the eRx business in the ordinary course or invest in the eRx business to maintain its competitiveness. 

 (4)    That the Echo Shareholders and eRx Network Holdings, Inc, and its
subsidiaries are express third party beneficiaries with respect to this Section C and may enforce the rights hereunder as if party hereto. 

D.    Authority. Each party hereto represents and warrants that it has all requisite corporate or limited liability
company, as applicable, power and authority to execute and deliver this Amendment and to perform its obligations hereunder; and the execution, delivery and performance of this Amendment has been duly authorized by all necessary corporate or limited
liability company, as applicable, action. 
 E.    Miscellaneous. 

a.    Counterparts. This Waiver and Amendment may be executed in two or more counterparts (including by facsimile
or other electronic means), each of which shall be deemed to constitute an original, but all of which together shall be deemed to constitute one and the same instrument. 

b.    Headings. Headings are for reference purposes only and do not limit or otherwise affect any of the substance
of this Waiver and Amendment. 
 c.    Continued Effectiveness. Except as expressly amended, modified or
supplemented in this Waiver and Amendment, the terms of the Stockholders Agreement and the LLCA remain unchanged, and, as amended by this Waiver and Amendment, shall remain in full force and effect, and each is hereby confirmed and ratified. For
avoidance of doubt, nothing herein shall be deemed to modify or impair the rights of the Members (as defined in the LLCA) pursuant to the LLCA, including, without limitation, the approval rights of the Members (as members of the IPO Committee) with
respect to the final pricing, size and other material terms of a Qualified IPO pursuant to Section 5.05(a)(xxvi) of the LLCA. 

d.    CHOICE OF LAW. THIS WAIVER AND AMENDMENT WILL BE GOVERNED BY, AND ENFORCED, CONSTRUED AND INTERPRETED IN
ACCORDANCE WITH, THE LAWS OF THE STATE OF DELAWARE APPLICABLE TO AGREEMENTS MADE AND TO BE PERFORMED ENTIRELY WITHIN SUCH STATE, WITHOUT REGARD TO ANY PRINCIPLES OF CONFLICT OF LAWS OF SUCH STATE THAT WOULD PROVIDE FOR THE APPLICATION OF THE LAWS OF
ANY OTHER JURISDICTION. 
 e.    Amendments. This Waiver and Amendment may not be amended except by an
instrument in writing and signed by each of the Parties hereto. 
 [Signatures Follow] 

 IN WITNESS WHEREOF, each of the parties hereto has caused this Waiver and Amendment to be
duly executed and delivered in its name and on its behalf, all as of the day and year first written above. 
  

			
	 BLACKSTONE CAPITAL PARTNERS VI L.P.

		
	By:	 	 Blackstone Management Associates VI L.L.C.,
 its
general partner

		
		 	By: BMA VI L.L.C., its sole member
		
	By:	 	/s/ Neil P. Simpkins
		 	 Name: Neil P. Simpkins
 Title:
  Senior Managing Director

  

			
	BLACKSTONE FAMILY INVESTMENT PARTNERSHIP VI L.P.
		
	By:	 	 BCP VI Side-By-Side GP L.L.C.,

its general partner

		
	By:	 	/s/ Neil P. Simpkins
		 	 Name: Neil P. Simpkins
 Title:
  Senior Managing Director

  

			
	BLACKSTONE FAMILY INVESTMENT PARTNERSHIP VI – ESC L.P.
		
	By:	 	 BCP VI Side-By-Side GP L.L.C.,

its general partner

		
	By:	 	/s/ Neil P. Simpkins
		 	 Name: Neil P. Simpkins
 Title:
  Senior Managing Director

  

			
	BLACKSTONE EAGLE PRINCIPAL TRANSACTION PARTNERS L.P.
		
	By:	 	 Blackstone Management Associates VI L.L.C.,
 its
general partner

		
		 	By: BMA VI L.L.C., its sole member
		
	By:	 	/s/ Neil P. Simpkins
		 	 Name: Neil P. Simpkins
 Title:
  Senior Managing Director

 [Signature Page to Waiver and Amendment] 

 IN WITNESS WHEREOF, each of the parties hereto has caused this Waiver and Amendment to be
duly executed and delivered in its name and on its behalf, all as of the day and year first written above. 
  

			
	 CHANGE HEALTHCARE INC.

		
	By:	 	/s/ Loretta A. Cecil
		 	 Name: Loretta A. Cecil
 Title:
  Executive Vice President, General Counsel

  

			
	 CHANGE HEALTHCARE LLC

		
	By:	 	/s/ Loretta A. Cecil
		 	 Name: Loretta A. Cecil
 Title:
  Executive Vice President, General Counsel

 [Signature Page to Waiver and Amendment] 

 IN WITNESS WHEREOF, each of the parties hereto has caused this Waiver and Amendment to be
duly executed and delivered in its name and on its behalf, all as of the day and year first written above. 
  

			
	 McKESSON CORPORATION

		
	By:	 	/s/ Britt J. Vitalone
		 	 Name: Britt J. Vitalone
 Title:
  Chief Financial Officer

  

			
	 PF2 IP LLC

		
	By:	 	/s/ Michele Lau
		 	 Name:
 Title:   

  

			
	 PF2 PST SERVICES INC.

		
	By:	 	/s/ Michele Lau
		 	 Name:
 Title:

 [Signature Page to Waiver and Amendment]EX-10.31

 Exhibit 10.31 

NONQUALIFIED STOCK OPTION AGREEMENT 

UNDER THE 
 HCIT
HOLDINGS, INC. AMENDED AND RESTATED 2009 EQUITY INCENTIVE PLAN 
 THIS STOCK OPTION AGREEMENT (the “Agreement”) by
and between HCIT Holdings, Inc., a Delaware corporation (the “Company”), and the individual named on the signature page hereto (the “Participant”) is made as of the date set forth on such signature page. 

R E C I T A L S: 

WHEREAS, the Company has adopted the Plan (as defined below), the terms of which are hereby incorporated by reference and made a part of this
Agreement; 
 WHEREAS, the Committee (as defined in the Plan) has determined that it would be in the best interests of the Company and its
stockholders to grant the Options (as defined below) provided for herein to the Participant pursuant to the Plan and the terms set forth herein; and 

WHEREAS, the Company owns no less than approximately 30% of the voting power of Change Healthcare LLC (the “JV”), with most
of the remaining voting power of the JV owned by McKesson Corporation (together with its affiliates, “McKesson”). 
 NOW,
THEREFORE, in consideration of the mutual covenants hereinafter set forth, the parties agree as follows: 
 1. Definitions. Whenever
the following terms are used in this Agreement, they shall have the meanings set forth below. Capitalized terms not otherwise defined herein shall have the same meanings as in the Plan. 

(a) Blackstone: “Blackstone” shall have the meaning ascribed to such term in the Stockholders’ Agreement. 

(b) Change of Control: “Change of Control” shall have the meaning ascribed to such term in the Plan. 

(c) Date of Grant: The “Date of Grant” specified on the signature page hereto. 

(d) Employment: “Employment” shall mean (i) a Participant’s employment if the Participant is an Employee of the
Company, the JV or any of their respective Subsidiaries on the date hereof, (ii) a Participant’s services as a Consultant or independent contractor, if the Participant is a Consultant to or independent contractor of the Company, the JV or
any of their respective Subsidiaries on the date hereof, and (iii) a Participant’s services as a Director, if the Participant is a non-employee director of the board of directors of the Company, the
JV or any of their respective Subsidiaries on the date hereof. 
 (e) Expiration Date: The tenth anniversary of the Date of Grant.

 (f) Option: An option with respect to which the terms and conditions are set forth in
Section 3(a) of this Agreement. 
 (g) Plan: Amended and Restated 2009 Equity Incentive Plan of HCIT Holdings, Inc., attached
hereto as Exhibit A, and as may be amended or supplemented from time to time in accordance with the terms thereof. 
 (h)
Stockholders’ Agreement: The Stockholders’ Agreement entered into by and among the Company and its stockholders dated as of March 1, 2017, attached hereto as Exhibit B, and as may be amended or supplemented from time to time in
accordance with the terms thereof, or any other similar agreement of one or more stockholders of the Company or a successor or issuer who assumes the Option granted under this Agreement designated by the Committee as a “Stockholders’
Agreement”. 
 (i) Transaction Date: The “Transaction Date” shall be March 1, 2017. 

(j) Vested Portion: At any time, the portion of the Option which has become vested in accordance with the terms of Section 3 of
this Agreement. 
 2. Grant of Options. The Company hereby grants to the Participant the right and option to purchase, on the terms
and conditions hereinafter set forth, all or any part of the number of Shares subject to the Option, as set forth on the signature page hereto, subject to adjustment as set forth in the Plan and this Agreement, and subject to the terms and
conditions set forth in this Agreement and the Plan. The exercise price per Share subject to the Option shall be the “Option Price” specified on the signature page hereto. The Option is intended to be a nonqualified stock option, and is
not intended to be treated as an option that complies with Section 422 of the Code. 
 3. Vesting of the Options; Expiration of
Unvested Options. 
 (a) Vesting of the Option. 

(i) Option. Subject to the Participant’s continued Employment through the applicable vesting date, the Option shall
vest and become exercisable with respect to twenty-five percent (25%) of the Shares subject to such Option on each of the first four anniversaries of the date specified as the “Vesting Start Date” on the signature page hereto. 

(ii) Change of Control. Notwithstanding the foregoing, in the event of a Change of Control during the Participant’s
continued Employment, the Option shall, to the extent not then vested or previously forfeited or cancelled, become fully vested and exercisable; provided, that no portion of the Option shall vest solely as a result of any transaction in which
McKesson disposes of or distributes equity owned by it in the JV to its shareholders. 
 (b) Termination of Employment. If the
Participant’s Employment terminates for any reason, the Option, to the extent not then vested and exercisable, shall be immediately canceled by the Company without consideration and the Vested Portion of an Option shall remain exercisable for
the period set forth in Section 4(a). 

  
 2 

 4. Exercise of Options. 

(a) Period of Exercise. Subject to the provisions of the Plan and this Agreement, the Participant may exercise all or any part of the
Vested Portion of an Option at any time prior to the Expiration Date. Notwithstanding the foregoing, if the Participant’s Employment terminates prior to the Expiration Date, the Vested Portion of an Option shall remain exercisable for the
period set forth below: 
 (i) Retirement, Death or Disability. If the Participant’s Employment is terminated due
to the Participant’s Retirement or death or by the Company during the Participant’s Disability, the Participant may exercise the Vested Portion of an Option during the period ending on the earlier of (x) one year following such
termination of Employment and (y) the Expiration Date; 
 (ii) Termination by the Company Other than for Cause, and
Other than Due to Death or Disability; Termination by the Participant for Good Reason. If (1) the Participant’s Employment is terminated by the Company not for Cause and not due to the Participant’s death or Disability or
(2) the Participant’s Employment is terminated by the Participant for Good Reason, the Participant may exercise the Vested Portion of an Option during the period ending on the earlier of (x) 120 days following such termination of
Employment and (y) the Expiration Date (or, if the Option only becomes vested and exercisable after such a termination of Employment, then the Participant may exercise the Vested Portion of such Option during the period ending on the earlier of
(x) 60 days following the date on which Option became vested and exercisable and (y) the Expiration Date); 
 (iii)
Termination by the Participant Other than for Good Reason or Retirement. If the Participant’s Employment is terminated by the Participant other than for Good Reason or Retirement, the Vested Portion of an Option shall terminate in full
and cease to be exercisable on the 30th day following such termination; and 

(iv) Termination by the Company for Cause; Restricted Activity. If the Participant’s Employment is terminated by
the Company for Cause or the Participant violates any provision of Section 5 of this Agreement, or any non-competition, non-solicitation, confidentiality, non-disparagement or other similar agreement between the Participant and the Company or any of its Affiliates (a “Restrictive Covenant Violation”), the Vested Portion of an Option shall immediately
terminate in full and cease to be exercisable. 
 Notwithstanding the foregoing, if the date an Option would otherwise terminate or expire occurs during a
period when trading in the Shares is prohibited by the Company’s insider trading policy (or a Company-imposed “blackout period”), then the Expiration Date or termination date shall be automatically be extended until the thirtieth
(30th) day following the expiration of such prohibition. 

  
 3 

 (b) Method of Exercise. 

(i) Subject to Section 4(a) of this Agreement and notwithstanding Section 6.4 of the Plan, the Vested Portion of an
Option may be exercised (in whole or in part) by delivering to the Company at its principal office written notice of intent to so exercise; provided that, the Option may be exercised with respect to whole Shares only. Such notice shall
specify the number of Shares for which the Option is being exercised and shall be accompanied by payment in full of the Option Price. The payment of the Option Price may be made at the election of the Participant (i) in cash or its equivalent
(e.g., by check or, if permitted by the Committee, a full-recourse promissory note), (ii) in Shares having a Fair Market Value equal to the aggregate Option Price for the Shares being purchased and satisfying such other reasonable
requirements as may be imposed by the Committee; provided, that such Shares have been held by the Participant for any period as established from time to time by the Committee in order to avoid adverse accounting treatment applying generally accepted
accounting principles, (iii) partly in cash and partly in such Shares, (iv) if there is a public market for the Shares at such time, to the extent permitted by the Committee and subject to such rules as may be established by the Committee,
through the delivery of irrevocable instructions to a broker to sell Shares obtained upon the exercise of the Option and to deliver promptly to the Company an amount out of the proceeds of such sale equal to the aggregate option price for the Shares
being purchased, or (v) using a net settlement mechanism whereby the number of Shares delivered upon the exercise of the Option will be reduced by a number of Shares that has a Fair Market Value equal to the Option Price. The Participant shall
not have any rights to dividends or other rights of a stockholder with respect to Shares subject to an Option until the Participant has given written notice of exercise of the Option, paid in full for such Shares and, if applicable, has satisfied
any other conditions imposed by the Committee pursuant to the Plan. 
 (ii) Notwithstanding any other provision of the Plan
or this Agreement to the contrary, absent an available exemption to registration or qualification, an Option may not be exercised prior to the completion of any registration or qualification of an Option or the Shares under applicable state and
federal securities or other laws, or under any ruling or regulation of any governmental body or national securities exchange that the Committee shall in its sole discretion determine to be necessary or advisable; provided, that the Company shall use
commercially reasonable efforts to take such actions as are necessary and appropriate to register or qualify the Shares subject to the Option so it may be exercised. 

(iii) Upon the Company’s determination that an Option has been validly exercised as to any of the Shares, the Company may
issue certificates in the Participant’s name for such Shares. However, the Company shall not be liable to the Participant for damages relating to any delays in issuing the certificates to the Participant, any loss by the Participant of the
certificates, or any mistakes or errors in the issuance of the certificates or in the certificates themselves. 

  
 4 

 (iv) In the event of the Participant’s death, the Vested Portion of an
Option shall remain exercisable by the Participant’s executor or administrator, or the person or persons to whom the Participant’s rights under this Agreement shall pass by will or by the laws of descent and distribution as the case may
be, to the extent set forth in Section 4(a) of this Agreement. Any heir or legatee of the Participant shall take rights herein granted subject to the terms and conditions hereof. 

(v) As a condition to the exercise of any Option evidenced by this Agreement, the Participant shall execute the
Stockholders’ Agreement designated by the Committee (provided that, if the Participant is already a party to the Stockholders’ Agreement, then the Shares acquired under the Option shall automatically become subject to such agreements
without any further action). 
 (c) Shares Issued Upon Exercise. Notwithstanding anything in the Stockholders’ Agreement to the
contrary, the Company and the Participant hereby acknowledge and agree that the Company shall only exercise the call rights set forth in Section 6.1(a)(iv) of the Stockholders’ Agreement with respect to Shares received by the Participant
pursuant to exercise of this Option if the Participant resigns his or her employment without Good Reason (and, for the avoidance of doubt, other than upon death or Disability) prior to the date that is eighteen months after the first day of the
Participant’s Employment with the Company (inclusive of prior service with Change Healthcare, Inc. or McKesson). 
 5. Confidential
Information; Post-Employment Obligations. 
 (a) Terms of Agreement. The terms of this Agreement constitute confidential
information, which Participant shall not disclose to anyone other than Participant’s spouse, attorneys, tax advisors, or as required by law. The Company and its Affiliates (which for purposes of this Section 5 will include the JV and its
Affiliates) may disclose the terms of this Agreement, provided, that for the purposes of this Section 5, Blackstone Group, L.P., Hellman & Friedman LLC, McKesson and any of their respective Affiliates (other than the Company and its
Subsidiaries and the JV and its Subsidiaries) shall not be considered “Affiliates” of the Company. 
 (b) Restrictive
Covenants. The Participant acknowledges and agrees that the Participant has agreed to certain covenants regarding non-competition, non-solicitation, non-disparagement, confidentiality, and other restrictions, which are contained herein or are hereby incorporated by reference, which are in consideration for Participant’s receiving the grant of the Option
under this Agreement and right to benefits upon certain terminations of Employment as provided in Section 3(b), receiving other benefits provided in this Agreement and elsewhere, and access to Confidential Information of the Company Group. For
this purpose, “Confidential Information” means and includes the confidential and/or proprietary information and/or trade secrets of the Company Group that have been developed or used and/or will be developed and that cannot be obtained
readily by third parties from outside sources, and any references to “affiliates” in any provisions or agreements related to non-disparagement entered into by the Participant shall be deemed to
include The Blackstone Group, L.P., Hellman & Friedman LLC, and McKesson. 

  
 5 

 6. Repayment of Proceeds. If the Participant’s Employment is terminated by a
Service Recipient for Cause or a Restrictive Covenant Violation occurs, or a Service Recipient discovers after a termination of Employment that grounds for a termination with Cause existed at the time thereof, then the Participant shall be required
to pay to the Company or the Company’s designee, within 10 business days’ of the request to the Participant therefor so long as such request is provided to the Participant within the 18 months immediately following the Participant’s
termination of Employment (or in the case of a Restrictive Covenant Violation, 18 months from the date of the Service Recipient’s actual knowledge of such Restrictive Covenant Violation), an amount equal to the excess, if any, of (a) the
aggregate after-tax proceeds (taking into account all amounts of tax that would be recoverable upon a claim of loss for payment of such proceeds in the year of repayment) the Participant received upon the sale
or other disposition of, or distributions in respect of, Shares acquired under any Option over (b) the aggregate price paid by the Participant for such Shares. Any reference in this Agreement to grounds existing for a termination with Cause
shall be determined without regard to any notice period, cure period or other procedural delay or event required prior to finding of, or termination for, Cause. The foregoing remedy shall not be exclusive. 

7. No Right to Continued Employment. Neither the Plan nor this Agreement shall be construed as giving the Participant the right to be
retained in the employ of, or in any consulting relationship to, the Service Recipient. Further, the Service Recipient may at any time dismiss the Participant or discontinue any consulting relationship, free from any liability or any claim under the
Plan or this Agreement, except as otherwise expressly provided herein. 
 8. Legend on Certificates. The certificates representing the
Shares purchased by exercise of an Option shall be subject to such stop transfer orders and other restrictions as the Committee may deem advisable under the Plan or the rules, regulations, and other requirements of the Securities and Exchange
Commission, any stock exchange upon which such Shares are listed or quoted or market to which the Shares are admitted for trading and, any applicable federal or state or any other applicable laws and the Company’s Certificate of Incorporation
and Bylaws, and the Committee may cause a legend or legends to be put on any such certificates to make appropriate reference to such restrictions. 

9. Transferability. An Option may not be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered by the
Participant otherwise than by will or by the laws of descent and distribution, and any such purported assignment, alienation, pledge, attachment, sale, transfer or encumbrance shall be void and unenforceable against the Company or any Affiliate;
provided that the designation of a beneficiary shall not constitute an assignment, alienation, pledge, attachment, sale, transfer or encumbrance. No such permitted transfer of an Option to heirs or legatees of the Participant shall be
effective to bind the Company unless the Committee shall have been furnished with written notice thereof and a copy of such evidence as the Committee may deem necessary to establish the validity of the transfer and the acceptance by the transferee
or transferees of the terms and conditions thereof. During the Participant’s lifetime, an Option is exercisable only by the Participant. 

  
 6 

 10. Withholding. Upon the exercise of any Option, or at any such time as required
under applicable law, the Participant shall be required to pay to the Company or any Affiliate in cash and the Company or its Affiliates shall have the right and are authorized to, withhold any applicable withholding taxes in respect of an Option,
its exercise, or any payment or transfer under or with respect to an Option and to take such other action as may be necessary in the opinion of the Committee to satisfy all obligations for the payment of such withholding taxes. Notwithstanding the
foregoing, at any time when the Company’s Shares are listed on a national or regional securities exchange or market system, or Share prices are quoted on the Over the Counter Bulletin Board, the Participant may elect to have such withholding
obligation satisfied by surrendering to the Company or any Affiliate a number of Shares obtained upon the exercise of an Option having a Fair Market Value equal to or greater than the minimum applicable amount necessary to satisfy Federal, state,
local or foreign withholding tax requirements, liabilities and obligations, if any (but which may in no event be greater than the maximum statutory withholding amounts in the Participant’s jurisdiction), and the Shares so surrendered by the
Participant shall be credited against any such withholding obligation at the Fair Market Value of such Shares on the date of such surrender. 

11. Securities Laws. Upon the acquisition of any Shares pursuant to the exercise of an Option, the Participant will make or enter into
such written representations, warranties and agreements as the Committee may reasonably request in order to comply with applicable securities laws or with this Agreement. 

12. Notices. Any notice under this Agreement shall be addressed as follows: 

if to the Company: 
 HCIT
Holdings, Inc. 
 c/o Change Healthcare, Inc. 

3055 Lebanon Pike, Suite 1000 

Nashville, TN 37214 
 Attention:
General Counsel 
 Fax: [fax number] 

with copies (which shall not constitute notice) to: 

The Blackstone Group, L.P. 
 345
Park Avenue 
 New York, NY 10152 

Attention: Neil P. Simpkins 

Tel: [telephone number] 
 Fax:
[fax number] 
 and 
 Simpson
Thacher & Bartlett LLP 
 425 Lexington Avenue 

New York, NY 10017 
 Attention:
Gregory Grogan 
 Tel: [telephone number] 

Fax: [fax number] 

  
 7 

 If to the Participant: 

At the address appearing in the personnel records of the Company or the JV for the Participant. 

Following the date hereof, notice may be delivered to either party at such other address as either party hereto may hereafter designate in writing to the
other. Any such notice shall be deemed effective upon receipt thereof by the addressee. 
 13. Governing Law. This Agreement shall be
governed by and construed in accordance with the laws of the State of Delaware without regard to conflicts of laws. 
 14. Option Subject
to Plan and Stockholders’ Agreement. By entering into this Agreement the Participant agrees and acknowledges that the Participant has received and read a copy of the Plan and the Stockholders’ Agreement. The Options and the Shares
received upon exercise of an Option are subject to the Plan and the Stockholders’ Agreement and as a condition of exercise of any Options, the Participant must join or agree to be bound by the Stockholders’ Agreement designated by the
Committee. For the avoidance of doubt, the Option shall be subject to the adjustment and modification provisions of the Plan. The terms and provisions of the Plan and the Stockholders’ Agreement, as each may be amended from time to time are
hereby incorporated by reference. In the event of a conflict between any term or provision contained herein and a term or provision of the Plan, the applicable terms and provisions of the Plan will govern and prevail. In the event of a conflict
between any term or provision contained herein and a term or provision of the Stockholders’ Agreement, the applicable terms and provisions of the Stockholders’ Agreement will govern and prevail. In the event of a conflict between any
applicable term or provision of the Plan and any term or provision of the Stockholders’ Agreement, the applicable terms and provisions of the Stockholders’ Agreement will govern and prevail. 

15. Amendment. The Committee may waive any conditions or rights under, amend any terms of, or alter, suspend, discontinue, cancel or
terminate this Agreement, but no such waiver, amendment, alteration, suspension, discontinuance, cancellation or termination shall materially diminish the rights of the Participant hereunder without the consent of the Participant unless such action
is made in accordance with the terms of the Plan. 
 16. Entire Agreement. This Agreement and the documents referred to herein or
delivered pursuant hereto which form a part hereof contain the entire understanding of the parties with respect to the subject matter hereof and thereof, provided, that if any member of the Company Group is a party to one or more agreements
with Participant related to the matters subject to Section 5, such other agreements shall remain in full force and effect and continue in addition to this Agreement, including, for the avoidance of doubt, those certain covenants set forth in
any Trade Secret and Proprietary Information Agreement and/or Company Protection Agreement entered into with a member of the Company Group (which covenants do not supersede or replace any other confidentiality,
non-competition, non-solicitation, non-disparagement or similar agreement entered into between the Participant and any member of
the Company Group to the extent that such agreement is more protective of the business of the 

  
 8 

 
Company Group), and provided further, that to the extent a Participant is party to any agreement that would, by its terms, vary the terms of this Agreement (other than with respect
to the matters subject to Section 5 hereof) or the Stockholders’ Agreement (or provide more favorable rights and remedies to the Participant), such terms will be deemed amended and shall not apply to the Options granted herein or any
Shares acquired under the Option. There are no restrictions, agreements, promises, representations, warranties, covenants or undertakings with respect to the subject matter hereof other than those expressly set forth herein and therein. This
Agreement supersedes all prior agreements and understandings between the parties with respect to such subject matter, other than as specifically provided for herein. 

17. Signature in Counterparts. This Agreement may be signed in counterparts, each of which shall be an original, with the same effect as
if the signatures thereto and hereto were upon the same instrument. 
 [The remainder of this page intentionally left blank.] 

  
 9 

					
	Total Options:	    		    	Option Price: $2,400
	Vesting Start Date:	    	                                      
                                    	    	
	Date of Grant:	    		    	

  

	
	Participant:
	  

	Name:
	
	Date:
	Address:
	  

	  

 
			
	 Agreed and accepted:

	
	HCIT HOLDINGS, INC.
		
	 By:
	 	  

		 	 Name:

		 	 Title:

 Exhibit A 

Plan 
 (Distributed
Separately) 

 Exhibit B 

Stockholders’ Agreement 

(Distributed Separately)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00303-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00303-of-00352.parquet"}]]